FDA Blood Products Advisory Committee
Executive Summary
Will discuss recommendations for blood and blood products testing and licensure at its Nov. 18 meeting. The panel will also review a premarket approval for Ortho's test for hepatitis B core antibody. The meeting will start at 8:00 a.m. in conference rooms G and H at FDA's Parklawn Building, Rockville, Maryland.